Publication:
Effectiveness of Cladribine Compared to Fingolimod, Natalizumab, Ocrelizumab and Alemtuzumab in Relapsing-Remitting Multiple Sclerosis

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Roos, Izanne/0000-0003-0371-3666; Malpas, Charles/0000-0003-0534-3718;

Keywords

Citation

WoS Q

Q1

Scopus Q

Q1

Source

Multiple Sclerosis Journal

Volume

29

Issue

Start Page

629

End Page

631

Endorsement

Review

Supplemented By

Referenced By